Blame and shame are killing our clients: How behavioral health stigma biases providers and undermines smoking cessation, co-hosted by NBHN

Duration:

60 Minutes

Webinar Speakers

Jason Satterfield, PhD

Academy Endowed Chair for Innovation in Teaching and Professor of Clinical Medicine at the University of California, San Francisco

Jason M. Satterfield, PhD is the Academy Endowed Chair for Innovation in Teaching and Professor of Clinical Medicine in the Division of General Internal Medicine at the University of California San Francisco. He received his Bachelor of Science in brain sciences from MIT and his Ph.D. in clinical psychology from the University of Pennsylvania. Dr. Satterfield’s current interests include the integration of behavioral science in medical education, dissemination and implementation of evidence-based behavioral practices in primary care, and emerging mobile health technologies for behavioral health with a particular focus on smoking and substance use disorders. His current projects include training and implementation of medication-assisted treatment for opioid use disorders, the development and administration of the National Center for Tobacco Free Recovery, screening and brief interventions for substance misuse and tobacco, and the integration of social and behavioral sciences in medical, nursing, and social work curricula.

Webinar Objectives
  1. Define and describe stigma as it relates to behavioral health disorders, smoking, and substance use.

  2. Describe the social and psychological processes that create stigma and cause it to be internalized.

  3. Summarize how stigma affects both client and provider behavior and contributes to health and health care disparities.

  4. Compare and contrast two interventions intended to reduce stigma, expand access to treatment, and improve outcomes for smoking and other behavioral health disorders.

Instructions for CME/CEU Credit

CME/CEUs are available for the recorded version of this webinar. Click on the "Get Credit" button to begin.

CERTIFICATES OF ATTENDANCE

If you need a certificate of attendance for your contact hour earned for this webinar, click here.

ACCME Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.

Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.

Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.

 

Disclosures

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:

Christine Cheng, Brian Clark, Jennifer Lucero, MA, MS, Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, Jessica Safier, MA, Jason M. Satterfield, PhD, Catherine Saucedo, Steven A. Schroeder, MD and Aria Yow, MA.

 

Additional Resources